Dacula, Camar C.
HRN: 21-53-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2022
CEFUROXIME 1.5GM (VIAL)
07/14/2022
07/21/2022
IV
1.5g
Q8
PTB; URTI
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaURTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes